StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) stock

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.42−0.06 (-4.05%)

Close on Nov 17, 2026Market cap $53.14MP/E –Yield –

Tenax Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Tenax Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$46.03M. For fiscal 2025 it was -$35.80M. The highest annual figure on record is -$4.92M in fiscal 2013.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$35.80M–
FY2024Dec 31, 2024-$14.81M–
FY2023Dec 31, 2023-$5.90M–
FY2022Dec 31, 2022-$11.39M–
FY2021Dec 31, 2021-$10.86M–
FY2020Dec 31, 2020-$9.27M–
FY2019Dec 31, 2019-$7.56M–
FY2018Dec 31, 2018-$5.50M–
FY2017Dec 31, 2017-$12.14M–
FY2015Apr 30, 2015-$9.75M–
FY2014Apr 30, 2014-$9.26M–
FY2013Apr 30, 2013-$4.92M–
FY2012Apr 30, 2012-$8.28M–
FY2011Apr 30, 2011-$8.40M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026-$14.15M–
Q1 FY2026CQ1 2026Mar 31, 2026-$9.31M–
Q4 FY2025CQ4 2025Dec 31, 2025-$13.42M–
Q3 FY2025CQ3 2025Sep 30, 2025-$9.16M–
Q2 FY2025CQ2 2025Jun 30, 2025-$6.26M–
Q1 FY2025CQ1 2025Mar 31, 2025-$6.97M–
Q4 FY2024CQ4 2024Dec 31, 2024-$3.53M–
Q3 FY2024CQ3 2024Sep 30, 2024-$3.09M–
Q2 FY2024CQ2 2024Jun 30, 2024-$3.03M–
Q1 FY2024CQ1 2024Mar 31, 2024-$5.17M–
Q4 FY2023CQ4 2023Dec 31, 2023-$1.18M–
Q3 FY2023CQ3 2023Sep 30, 2023-$2.08M–
Q2 FY2023CQ2 2023Jun 30, 2023-$922.97K–
Q1 FY2023CQ1 2023Mar 31, 2023-$1.72M–
Q4 FY2022CQ4 2022Dec 31, 2022-$1.69M–
Q3 FY2022CQ3 2022Sep 30, 2022-$3.33M–
Q2 FY2022CQ2 2022Jun 30, 2022-$3.43M–
Q1 FY2022CQ1 2022Mar 31, 2022-$2.94M–
Q4 FY2021CQ4 2021Dec 31, 2021-$2.77M–
Q3 FY2021CQ3 2021Sep 30, 2021-$3.02M–
Q2 FY2021CQ2 2021Jun 30, 2021-$1.85M–
Q1 FY2021CQ1 2021Mar 31, 2021-$3.22M–
Q4 FY2020CQ4 2020Dec 31, 2020-$1.99M–
Q3 FY2020CQ3 2020Sep 30, 2020-$2.39M–
Q2 FY2020CQ2 2020Jun 30, 2020-$2.23M–
Q1 FY2020CQ1 2020Mar 31, 2020-$2.67M–
Q4 FY2019CQ4 2019Dec 31, 2019-$1.73M–
Q3 FY2019CQ3 2019Sep 30, 2019-$1.78M–
Q2 FY2019CQ2 2019Jun 30, 2019-$1.91M–
Q1 FY2019CQ1 2019Mar 31, 2019-$2.13M–
Q4 FY2018CQ4 2018Dec 31, 2018-$1.20M–
Q3 FY2018CQ3 2018Sep 30, 2018-$1.56M–
Q2 FY2018CQ2 2018Jun 30, 2018-$1.19M–
Q1 FY2018CQ1 2018Mar 31, 2018-$1.56M–
Q4 FY2017CQ4 2017Dec 31, 2017-$1.28M–
Q3 FY2017CQ3 2017Sep 30, 2017-$1.23M–
Q2 FY2017CQ2 2017Jun 30, 2017-$5.60M–
Q1 FY2017CQ1 2017Mar 31, 2017-$4.04M–
Q4 FY2015CQ1 2015Apr 30, 2015-$1.63M–
Q3 FY2015CQ4 2014Jan 31, 2015-$3.23M–

More Tenax Therapeutics figures

See a number that looks wrong?